Persistent luminescence phosphors are a novel group of promising luminescent materials
with afterglow properties after the stoppage of excitation. In the past decade, persistent …

The field of advanced nanotechnology is brimming with a plethora of nanotheranostics
whose combinatorial synergistic applicability in treating malignant tumors is tremendous. But …

Persistent luminescence nanoparticles (PLNPs) are unique optical materials that emit
afterglow luminescence after ceasing excitation. They exhibit unexpected advantages for in …

Persistent luminescent nanoparticles (PLNPs) with intrinsic stimuli‐responsive properties
are desirable because of no autofluorescence background and natural responsive …

Aptamers are short single-stranded RNA or DNA molecules that can recognize a series of
targets with high affinity and specificity. Known as “chemical antibodies”, aptamers have …

Low tumor delivery efficiency is a critical barrier in cancer nanomedicine. This study reports
an updated version of “Nano-Tumor Database”, which increases the number of time …

Over recent years, advancements in nanomedicine have allowed new approaches to
diagnose and treat tumors. Nano drug delivery systems exploit the enhanced permeability …

Glioblastoma (GBM) is the most prevailing malignant primary brain tumor, and the precise
diagnosis of GBM has always been a challenge. Gboxin is a recently developed drug …

Theranostic nano-drug delivery systems are promising candidates for early diagnosis and
treatment of tumors. However, it is a great challenge to achieve accurate intracellular …

Fluorescence imaging plays an important role in early diagnosis and surgical resection of
cancer because of its real-time, noninvasiveness, high sensitivity, and resolution. Compared …